Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Bliss GVS Pharma has reported total income of Rs. 242.92 crores during the period ended June 30, 2025
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Subscribe To Our Newsletter & Stay Updated
